These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 30097754

  • 61. ALTERATIONS IN HISTIDINE METABOLISM IS A FEATURE OF EARLY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD).
    Chapman A, Chen P.
    Trans Am Clin Climatol Assoc; 2024; 134():47-65. PubMed ID: 39135565
    [Abstract] [Full Text] [Related]

  • 62. PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients.
    Ali H, Alahmad B, Senum SR, Warsame S, Bahbahani Y, Abu-Farha M, Abubaker J, Alqaddoumi M, Al-Mulla F, Harris PC.
    Am J Nephrol; 2024; 55(3):380-388. PubMed ID: 38194940
    [Abstract] [Full Text] [Related]

  • 63. Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease.
    Eroglu E, Kocyigit I, Cetin M, Zararsiz G, Imamoglu H, Bayramov R, Tastan S, Sipahioglu MH, Tokgoz B, Oymak O.
    Clin Exp Nephrol; 2019 Oct; 23(10):1188-1195. PubMed ID: 31165946
    [Abstract] [Full Text] [Related]

  • 64. Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.
    Kim H, Koh J, Park SK, Oh KH, Kim YH, Kim Y, Ahn C, Oh YK.
    Nephrology (Carlton); 2019 Apr; 24(4):422-429. PubMed ID: 29797773
    [Abstract] [Full Text] [Related]

  • 65. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
    Brosnahan GM, Abebe KZ, Moore CG, Bae KT, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Rahbari-Oskoui FF, Steinman TI, Torres VE, The Halt Pkd Investigators.
    Curr Hypertens Rev; 2018 Apr; 14(1):39-47. PubMed ID: 29564978
    [Abstract] [Full Text] [Related]

  • 66. Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
    Gansevoort RT, Hariri A, Minini P, Ahn C, Chapman AB, Horie S, Knebelmann B, Mrug M, Ong ACM, Pei YPC, Torres VE, Modur V, Antonshchuk I, Perrone RD.
    Am J Kidney Dis; 2023 May; 81(5):517-527.e1. PubMed ID: 36535535
    [Abstract] [Full Text] [Related]

  • 67. [Research progress in autosomal dominant polycystic kidney disease].
    Hu S, Li D, Tan X, Gu J, Chen M, Zhang X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Oct 28; 44(10):1179-1187. PubMed ID: 31857514
    [Abstract] [Full Text] [Related]

  • 68. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
    Riyahi S, Dev H, Blumenfeld JD, Rennert H, Yin X, Attari H, Barash I, Chicos I, Bobb W, Donahue S, Prince MR.
    J Magn Reson Imaging; 2021 Feb 28; 53(2):564-576. PubMed ID: 32969110
    [Abstract] [Full Text] [Related]

  • 69. Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease.
    Siedek F, Grundmann F, Weiss K, Pinto Dos Santos D, Arjune S, Haneder S, Persigehl T, Müller RU, Baessler B.
    Invest Radiol; 2020 Apr 28; 55(4):217-225. PubMed ID: 31876626
    [Abstract] [Full Text] [Related]

  • 70. Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression.
    Pejchinovski M, Siwy J, Metzger J, Dakna M, Mischak H, Klein J, Jankowski V, Bae KT, Chapman AB, Kistler AD.
    Nephrol Dial Transplant; 2017 Mar 01; 32(3):487-497. PubMed ID: 27382111
    [Abstract] [Full Text] [Related]

  • 71. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC, Kang AY, Jang JY, Kim H, Han M, Oh KH, Kim SH, Noh JW, Cheong HI, Hwang YH, Ahn C.
    BMC Nephrol; 2015 Jun 20; 16():86. PubMed ID: 26092580
    [Abstract] [Full Text] [Related]

  • 72. The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease.
    Ferraro PM, Bargagli M, Faller N, Anderegg MA, Huynh-Do U, Vogt B, Gambaro G, Fuster DG.
    J Nephrol; 2023 May 20; 36(4):1011-1018. PubMed ID: 36528688
    [Abstract] [Full Text] [Related]

  • 73. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
    Bhutani H, Smith V, Rahbari-Oskoui F, Mittal A, Grantham JJ, Torres VE, Mrug M, Bae KT, Wu Z, Ge Y, Landslittel D, Gibbs P, O'Neill WC, Chapman AB, CRISP Investigators.
    Kidney Int; 2015 Jul 20; 88(1):146-51. PubMed ID: 25830764
    [Abstract] [Full Text] [Related]

  • 74. Automated prognosis of renal function decline in ADPKD patients using deep learning.
    Raj A, Tollens F, Caroli A, Nörenberg D, Zöllner FG.
    Z Med Phys; 2024 May 20; 34(2):330-342. PubMed ID: 37612178
    [Abstract] [Full Text] [Related]

  • 75. Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease.
    Chen D, Ma Y, Wang X, Yu S, Li L, Dai B, Mao Z, Sun L, Xu C, Rong S, Tang M, Zhao H, Liu H, Serra AL, Graf N, Liu S, Wüthrich RP, Mei C.
    PLoS One; 2014 May 20; 9(3):e92232. PubMed ID: 24651850
    [Abstract] [Full Text] [Related]

  • 76. Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease.
    Blijdorp CJ, Severs D, Musterd-Bhaggoe UM, Gansevoort RT, Zietse R, Hoorn EJ, DIPAK Consortium.
    Nephrol Dial Transplant; 2021 Dec 02; 36(12):2248-2255. PubMed ID: 33377160
    [Abstract] [Full Text] [Related]

  • 77. Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study.
    Brosnahan GM, Wang W, Gitomer B, Struemph T, George D, You Z, Nowak KL, Klawitter J, Chonchol MB.
    Am J Kidney Dis; 2022 Apr 02; 79(4):518-526. PubMed ID: 34391872
    [Abstract] [Full Text] [Related]

  • 78. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.
    Jo WR, Kim SH, Kim KW, Suh CH, Kim JK, Kim H, Lee JG, Oh WY, Choi SE, Pyo J.
    Eur J Radiol; 2017 Oct 02; 95():56-65. PubMed ID: 28987699
    [Abstract] [Full Text] [Related]

  • 79. Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.
    Grau L, Gitomer B, McNair B, Wolf M, Harris P, Brosnahan G, Torres V, Steinman T, Yu A, Chapman A, Chonchol M, Nowak KL.
    Kidney360; 2020 Jul 02; 1(7):648-656. PubMed ID: 33305291
    [Abstract] [Full Text] [Related]

  • 80. Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease.
    Kramers BJ, Koorevaar IW, Drenth JPH, de Fijter JW, Neto AG, Peters DJM, Vart P, Wetzels JF, Zietse R, Gansevoort RT, Meijer E.
    Kidney Int; 2020 Oct 02; 98(4):989-998. PubMed ID: 32534051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.